These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1465886)

  • 21. Renal tubular cell necrosis and apoptosis in transplanted kidneys.
    Toronyi E; Lord R; Bowen ID; Perner F; Szende B
    Cell Biol Int; 2001; 25(3):267-70. PubMed ID: 11352501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of endothelin in renal function and dysfunction.
    Brooks DP
    Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):345-48. PubMed ID: 8717072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of 214 percutaneous renal allograft biopsies.
    Kim HC; Park SB; Lee SH; Cho WH; Park CH; Park KK
    Transplant Proc; 1994 Aug; 26(4):1997-8. PubMed ID: 8066648
    [No Abstract]   [Full Text] [Related]  

  • 25. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
    Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
    Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
    Morozumi K; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary thromboxane B2 and cyclic AMP in cyclosporine-A-treated kidney transplantation.
    Quereda C; Sabater J; Villafruela J; Revalderia JG; Marcen R; Ortuño J
    Transplant Proc; 1994 Oct; 26(5):2604-5. PubMed ID: 7940810
    [No Abstract]   [Full Text] [Related]  

  • 30. [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].
    Chomette G; Auriol M; Beaufils H; Rottembourg A; Cabrol C
    Ann Pathol; 1986; 6(1):29-36. PubMed ID: 3521626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One hundred eighty graft biopsies in cyclosporine-treated kidney transplants.
    Yagisawa T; Takahashi K; Toma H; Teraoka S; Yamaguchi Y; Agishi T; Ota K
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):772-6. PubMed ID: 3291312
    [No Abstract]   [Full Text] [Related]  

  • 32. Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats.
    Prescott-Mathews JS; Wolf DC; Wong BA; Borghoff SJ
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):301-14. PubMed ID: 9144447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA?
    Takeda A; Morozumi K; Uchida K; Yokoyama I; Takagi H; Yoshida A; Fujinami T; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):515-7. PubMed ID: 8438396
    [No Abstract]   [Full Text] [Related]  

  • 34. Interstitial alterations in renal cortex in acute tubular necrosis (ATN) post-renal transplantation and in patients with ATN not related to renal transplant.
    Moyses Neto M; Costa RS; Volpini RA; Garcia TM; Rodrigues FF; Coimbra TM
    Clin Transplant; 2004 Apr; 18(2):156-65. PubMed ID: 15016130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection.
    Marcussen N; Lai R; Olsen TS; Solez K
    Transplant Proc; 1996 Feb; 28(1):470-6. PubMed ID: 8644316
    [No Abstract]   [Full Text] [Related]  

  • 36. Early segmental changes in ischemic acute tubular necrosis of the rat kidney.
    Faarup P; Holstein-Rathlou NH; Nørgaard T; Hegedüs V
    APMIS; 2004 Mar; 112(3):192-200. PubMed ID: 15153161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine-associated thrombotic microangiopathy: report of two cases with good outcome and successful subsequent reuse.
    Dhib M; Moulin B; Abderrahim E; Etienne I; Godin M; Fillastre JP
    Transplant Proc; 1993 Jun; 25(3):2294-6. PubMed ID: 8516905
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical algorithms for cyclosporine management based on pathophysiologic constructs of nephrotoxicity.
    Bennett WM
    Transplant Proc; 1994 Oct; 26(5):2583-4. PubMed ID: 7940801
    [No Abstract]   [Full Text] [Related]  

  • 39. TNF staining of graft biopsy in renal transplantation.
    Aikawa A; McLaughlin PJ; Davies HS; Johnson PM; McDicken I; Bakran A; Sells RA
    Transpl Int; 1992; 5 Suppl 1():S651-2. PubMed ID: 14621900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe endothelial injury in a renal transplant patient receiving cyclosporine.
    Fogo A; Hakim RC; Sugiura M; Inagami T; Kon V
    Transplantation; 1990 Jun; 49(6):1190-2. PubMed ID: 2193445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.